Call for Abstract

Scientific Program

4th International Conference and Exhibition on Obesity and Weight Management, will be organized around the theme “To Share Preventive & Management Strategies for Obesity. ”

Obesity 2015 is comprised of 12 tracks and 70 sessions designed to offer comprehensive sessions that address current issues in Obesity 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 1:Basic Science of Obesity and Overweight

Obesity is a medical condition in which excess body fat has accumulated to the extent that it may have a negative effect on health, leading to reduced life expectancy and/or increased health problems. In Western countries, people are considered obese when their body mass index (BMI), a measurement obtained by dividing a person's weight by the square of the person's height, exceeds 30 kg/m2, with the range 25-30 kg/m2 defined as overweight. In earlier historical periods obesity was rare, and achievable only by small elite, although already recognized as a problem for health. But as prosperity increased in the Early Modern period, it affected increasingly larger groups of the population. In 1997 the WHO formally recognized obesity as a global epidemic. As of 2008 the WHO estimates that at least 500 million adults (greater than 10%) are obese, with higher rates among women than men. The rate of obesity also increases with age at least up to 50 or 60 years old and severe obesity in the United States, Australia, and Canada is increasing faster than the overall rate of obesity.
Once considered a problem only of high-income countries, obesity rates are raising worldwide and affecting both the developed and developing world. These increases have been felt most dramatically in urban settings. The only remaining region of the world where obesity is not common is sub-Saharan Africa. Obesity is a complex disease resulting from the interactions of a wide variety of hereditary and environmental factors. The combined progress in quantitative genetics, genomics and bioinformatics has contributed to a better understanding of the genetic and molecular basis of obesity.
  • Track 1-1Obesity
  • Track 1-2Cellular, molecular and genetic bases of obesity
  • Track 1-3Body mass index measurements in men and women
  • Track 1-4Adipocyte function and immune metabolism
  • Track 1-5Developmental origins of obesity
  • Track 1-6Steroids and hormones in obesity
  • Track 1-7Life expectancy
  • Track 1-8Epidemics-public health, environmental and economic issues
  • Track 1-9Role of physiological and biochemical changes in obesity

Track 2:Childhood Obesity and its Lifelong Effects

  • Track 2-1Dietary effects and sedentary life style
  • Track 2-2Developmental, genetical and environmental factors
  • Track 2-3Behavior and psychological factors
  • Track 2-4Metabolic consequences and psychosocial factors
  • Track 2-5Long-term health effects of childhood obesity
  • Track 2-6Prevention and awareness
  • Track 2-7Pediatric obesity

Track 3:Health Risks Associated With Obesity

Excessive body weight is associated with various diseases, particularly cardiovascular diseases, diabetes mellitus type 2, obstructive sleep apnea, certain types of cancers, osteoarthritis and asthma. Obesity increases the risk of many physical and mental conditions. These comorbidities are most commonly shown in metabolic syndrome, a combination of medical disorders which includes: diabetes mellitus type 2, high blood pressure, high blood cholesterol, and high triglyceride levels.
Overweight and obesity are associated with increased risk for many types of cancer, including cancer of the breast, colon, endometrium, esophagus, kidney, pancreas, gall bladder, thyroid, ovary, cervix, and prostate, as well as multiple myeloma and Hodgkin’s lymphoma. As a result, obesity has been found to reduce life expectancy
  • Track 3-1Cancer risk and obesity
  • Track 3-2Hypertension
  • Track 3-3Cardiovascular risk
  • Track 3-4Dyslipidemia
  • Track 3-5Depression and anxiety in obese patients
  • Track 3-6Gynecological problems & sexual health issues
  • Track 3-7Obesity and infertility
  • Track 3-8Alzheimer’s disease
  • Track 3-9Obesity and dementia
  • Track 3-10Obesity and thyroid

Track 4:Nutrition and Healthy Lifestyle

  • Track 4-1Calorie count and low fat energy restricted diet
  • Track 4-2Diet, exercise, behavior and lifestyle interventions
  • Track 4-3Malnutrition in children and adolescence
  • Track 4-4Growth and development
  • Track 4-5Physical activity and obesity
  • Track 4-6Nutrition and heamodialysis
  • Track 4-7Inflammatory, immune diseases & immune-boosting
  • Track 4-8Psychology
  • Track 4-9Anti-aging

Track 5:Obesity and Diabetes: Current Research Trends

  • Track 5-1Obesity and type 2 diabetes
  • Track 5-2Insulin and islet biology
  • Track 5-3Genetics of diabetes
  • Track 5-4Diabetes and its complications
  • Track 5-5Advance technologies for treatment of diabetes
  • Track 5-6Transplantation for diabetes

Track 6:Endocrinology and its Effects

Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood and sensory perception caused by hormones. A neuroendocrine signal is a "classical" hormone that is released into the blood by a neurosecretory neuron. Endocrine disruptors are chemicals that may interfere with the body’s endocrine system and produce adverse developmental, reproductive, neurological, and immune effects in both humans and wildlife.
  • Track 6-1Molecular and genetic endocrinology
  • Track 6-2Clinical practice and research of endocrine metabolic diseases
  • Track 6-3Endocrine and metabolic diseases public health and prevention
  • Track 6-4Treatment and diagnosis of endocrine diseases
  • Track 6-5Neuroendocrinology

Track 7:Surgical and Non-surgical Treatments

Bariatric surgery (weight loss surgery) includes a variety of procedures performed on people who have obesity. Weight loss is achieved by reducing the size of the stomach with a gastric band or through removal of a portion of the stomach (sleeve gastrectomy or biliopancreatic diversion with duodenal switch) or by resecting and re-routing the small intestine to a small stomach pouch (gastric bypass surgery). For obese patients, surgical intervention is an option and is frequently the treatment of choice. Non-surgical liposuction techniques use laser energy, radiofrequency, ultrasound or cold (cryolipolysis) to reduce fat. Although fat loss is more subtle with non-surgical lipolysis techniques compared to surgical liposuction, non-surgical lipolysis techniques have several advantages including reduced risk, reduced cost, and reduced healing time. Plastic surgery can play a very important part relative to massive weight loss. It is already well known that fat pads can be removed either by aesthetic or plastic surgery. More recently, surgeons have been exploring methods of plastic reconstruction after massive weight-loss, such as that obtained after digestive surgery. Bariatric surgeons should be aware that some of their patients will need heavy and painful reconstructive procedures. After common plastic surgery procedures, obese patients have more complications and make more hospital visits-leading to higher healthcare costs.
  • Track 7-1Bariatric surgery
  • Track 7-2Surgical and non-surgical liposuction
  • Track 7-3Post-operative surgical outcome in obesity
  • Track 7-4Plastic surgery and obesity- what’s the connection?
  • Track 7-5Surgical treatments of endocrine diseases

Track 8:Clinical Research and Interventions

Weight management is a long-term approach to a healthy lifestyle. It includes a balance of healthy eating and physical exercise to equate energy expenditure and energy intake. Treatments for obesity range from healthy eating and exercise, to prescription medicine and surgery. FDA-regulated medical devices have also played a role in treating obesity. Currently, there are three FDA-approved devices on the market designed to treat obesity: Lap-Band Gastric Banding System, Realize Gastric Band, and The Maestro Rechargable System. When assessing popular diets, it’s important to understand that a person’s food preferences, lifestyle and medical conditions should be taken into account when choosing the correct diet. Also “dieting” needs to be a lifestyle change and can’t just be for a short term amount of time. Along with diet, exercise, and behavior modification, drug therapy may be a helpful component of treatment for patients who are overweight or obese. The role of drug therapy has been questioned, however, because of concerns about efficacy, safety, and the observation that body weight slows and then plateaus with continued treatment, and most patients regain weight when their weight-loss drugs are stopped. Anti-obesity drugs can be useful adjuncts to diet and exercise for adults with obesity and a BMI greater than 30 kg/m2, who have failed to achieve weight loss goals through diet and exercise alone.
  • Track 8-1Weight management and behavior theories: Recent developments
  • Track 8-2Probiotics for human health -new innovations and emerging trends
  • Track 8-3Use of nanotechnology to alter the structure of different foods
  • Track 8-4Microarray analysis of obesity
  • Track 8-5Nutritional Genomics: Reading the future
  • Track 8-6Drug treatments and devices for obesity: Current research

Track 9:Weight Management Strategies

  • Track 9-1Exercise and physical stress
  • Track 9-2Low calorie and fiber diet
  • Track 9-3Pharmacotherapy
  • Track 9-4Weight watchers & diet protocols
  • Track 9-5Lifestyle changes
  • Track 9-6Yoga & physical therapy

Track 10:New Trends in Weight Loss Management

Hundreds of fad diets, weight-loss programs and outright scams promise quick and easy weight loss. However, the foundation of successful weight management remains a healthy, calorie-controlled diet combined with exercise. For successful, long-term weight loss, you must make permanent changes in your lifestyle and health habits.
  • Track 10-1Obesity and Weight Management
  • Track 10-2Fitness training- medical guidance and support
  • Track 10-3The high-protein diet and calorie-counting program
  • Track 10-4Alternative weight loss treatments.
  • Track 10-5IT & smart phone apps for dietary behavior changes
  • Track 10-6Fat burning foods & dietary recommendations
  • Track 10-7Nutritional Counseling

Track 11:Obesity and Diabetes: Current Research Trends

Obesity is a medical condition in which excess percentage body fat events has accumulated to the extent that it may have a negative effect on health, leading to reduced life expectancy and/or increased health problems. In Western countries, people are considered obese when their body mass index (BMI), a measurement obtained by dividing a person's weight by the square of the person's height, exceeds 30 kg/m2, with the range 25-30 kg/m2 defined as overweight. In earlier historical periods obesity was rare, and achievable only by a small elite, although already recognized as a problem for health. But as prosperity increased in the Early Modern period, it affected increasingly larger groups of the population. In 1997 the WHO formally recognized obesity as a global epidemic. As of 2008 the WHO estimates that at least 500 million adults (greater than 10%) are obese, with higher rates among women than men. The rate of obesity also increases with age at least up to 50 or 60 years old and severe obesity in the United States, Australia, and Canada is increasing faster than the overall rate of obesity.

Track 12:Obesity and Diabetes: Current Research Trends

Obesity is a medical condition in which excess percentage body fat events has accumulated to the extent that it may have a negative effect on health, leading to reduced life expectancy and/or increased health problems. In Western countries, people are considered obese when their body mass index (BMI), a measurement obtained by dividing a person's weight by the square of the person's height, exceeds 30 kg/m2, with the range 25-30 kg/m2 defined as overweight. In earlier historical periods obesity was rare, and achievable only by a small elite, although already recognized as a problem for health. But as prosperity increased in the Early Modern period, it affected increasingly larger groups of the population. In 1997 the WHO formally recognized obesity as a global epidemic. As of 2008 the WHO estimates that at least 500 million adults (greater than 10%) are obese, with higher rates among women than men. The rate of obesity also increases with age at least up to 50 or 60 years old and severe obesity in the United States, Australia, and Canada is increasing faster than the overall rate of obesity.

Once considered a problem only of high-income countries, obesity (Events) rates are raising worldwide and affecting both the developed and developing world. These increases have been felt most dramatically in urban settings. The only remaining region of the world where obesity is not common is sub-Saharan Africa. Obesity is a complex disease resulting from the interactions of a wide variety of hereditary and environmental factors. The combined progress in quantitative genetics, genomics and bioinformatics has contributed to a better understanding of the genetic and molecular basis of obesity.